SG11201509719SA - Heparan sulphate - Google Patents

Heparan sulphate

Info

Publication number
SG11201509719SA
SG11201509719SA SG11201509719SA SG11201509719SA SG11201509719SA SG 11201509719S A SG11201509719S A SG 11201509719SA SG 11201509719S A SG11201509719S A SG 11201509719SA SG 11201509719S A SG11201509719S A SG 11201509719SA SG 11201509719S A SG11201509719S A SG 11201509719SA
Authority
SG
Singapore
Prior art keywords
heparan sulphate
heparan
sulphate
Prior art date
Application number
SG11201509719SA
Inventor
Simon Cool
Victor Nurcombe
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Priority to SG11201509719SA priority Critical patent/SG11201509719SA/en
Publication of SG11201509719SA publication Critical patent/SG11201509719SA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23Carbohydrates
    • A61L2300/236Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201509719SA 2013-05-27 2014-05-27 Heparan sulphate SG11201509719SA (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG11201509719SA SG11201509719SA (en) 2013-05-27 2014-05-27 Heparan sulphate

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG2013040597 2013-05-27
SG11201509719SA SG11201509719SA (en) 2013-05-27 2014-05-27 Heparan sulphate
PCT/SG2014/000230 WO2014193308A1 (en) 2013-05-27 2014-05-27 Heparan sulphate

Publications (1)

Publication Number Publication Date
SG11201509719SA true SG11201509719SA (en) 2015-12-30

Family

ID=54784137

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201709698TA SG10201709698TA (en) 2013-05-27 2014-05-27 Heparan sulphate
SG11201509719SA SG11201509719SA (en) 2013-05-27 2014-05-27 Heparan sulphate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201709698TA SG10201709698TA (en) 2013-05-27 2014-05-27 Heparan sulphate

Country Status (13)

Country Link
US (2) US20160215072A1 (en)
EP (1) EP3004181B1 (en)
JP (1) JP6407980B2 (en)
KR (1) KR20160013200A (en)
CN (1) CN105358583B (en)
AU (1) AU2014271392B2 (en)
BR (1) BR112015029626A2 (en)
CA (1) CA2913734A1 (en)
HK (1) HK1221906A1 (en)
MX (1) MX2015016286A (en)
RU (1) RU2015155666A (en)
SG (2) SG10201709698TA (en)
WO (1) WO2014193308A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0818255D0 (en) 2008-10-06 2008-11-12 Agency Science Tech & Res Isolation and identification of glycosaminoglycans
US9498494B2 (en) 2008-09-11 2016-11-22 Agency For Science, Technology And Research Glycosaminoglycans
JP6916193B2 (en) * 2016-09-21 2021-08-11 グンゼ株式会社 A method for producing a porous base material made of a bioabsorbable polymer containing heparin, a porous base material made of a bioabsorbable polymer containing heparin, and an artificial blood vessel.
CN110907571B (en) * 2019-12-31 2022-07-05 湖北亿诺瑞生物制药有限公司 Method for detecting and analyzing heparan sulfate impurities in heparin sodium
WO2023141612A2 (en) * 2022-01-24 2023-07-27 University Of Florida Research Foundation, Incorporated Point of care testing system for antithrombin iii
WO2023239719A1 (en) * 2022-06-06 2023-12-14 Ihp Therapeutics Inc. Chemically modified heparin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019087A (en) 1986-10-06 1991-05-28 American Biomaterials Corporation Nerve regeneration conduit
US5491129A (en) * 1992-07-30 1996-02-13 Yeda Research And Development Co. Ltd. Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them
WO1996023003A1 (en) 1995-01-27 1996-08-01 Amrad Operations Pty. Ltd. A therapeutic molecule
US20080274156A1 (en) * 2005-05-06 2008-11-06 The University Of Queensland Composition forstimulating bone growth and differentiation and method for isolating same
US8716018B2 (en) * 2008-03-17 2014-05-06 Agency For Science, Technology And Research Microcarriers for stem cell culture
WO2009135888A2 (en) * 2008-05-06 2009-11-12 Octapharma Ag Complex
GB0818255D0 (en) * 2008-10-06 2008-11-12 Agency Science Tech & Res Isolation and identification of glycosaminoglycans

Also Published As

Publication number Publication date
US20190135949A1 (en) 2019-05-09
JP2016521775A (en) 2016-07-25
CN105358583B (en) 2019-02-15
EP3004181A4 (en) 2016-11-23
HK1221906A1 (en) 2017-06-16
BR112015029626A2 (en) 2017-09-26
EP3004181A1 (en) 2016-04-13
EP3004181B1 (en) 2019-01-02
CA2913734A1 (en) 2014-12-04
RU2015155666A (en) 2017-07-04
CN105358583A (en) 2016-02-24
AU2014271392B2 (en) 2018-05-10
JP6407980B2 (en) 2018-10-17
US20160215072A1 (en) 2016-07-28
SG10201709698TA (en) 2017-12-28
KR20160013200A (en) 2016-02-03
WO2014193308A1 (en) 2014-12-04
MX2015016286A (en) 2016-08-18
AU2014271392A1 (en) 2016-01-28

Similar Documents

Publication Publication Date Title
GB2511914B (en) Object production
HK1222664A1 (en) Heparan sulphates
HK1217316A1 (en) Photo-alignable object
GB201414400D0 (en) Object production
HK1221906A1 (en) Heparan sulphate
PL3044389T3 (en) Mullion-transom structure
HK1213036A1 (en) Tube-fastening structure
GB201417377D0 (en) Tower construction
GB201321922D0 (en) Constructions
GB201414328D0 (en) None
ZA201602177B (en) Tower construction
EP2979746A4 (en) Structure
GB201310730D0 (en) New structure
GB201305361D0 (en) Enhanced expression
PL2762668T3 (en) Connection profile
GB201311130D0 (en) Greensleeves I
DK3049043T3 (en) Indirekte tryk- og temperaturmåling i et totalt væskeventilationssystem
GB201410951D0 (en) None
EP2947069A4 (en) 5-hydroxy-1h-imidazole-4-carboxamide sulfate
GB201405962D0 (en) Closures
GB201410424D0 (en) None
GB201317272D0 (en) Object production
GB201316418D0 (en) Galectin Variant
GB201317353D0 (en) Ed
GB201314513D0 (en) Object production